Bellevue Life Sciences Ac...
(BLAC)
undefined
undefined%
At close: undefined
11.32
0.00%
After-hours Dec 12, 2024, 02:38 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 |
Net Income | 403.78K | -35.39K | -3.31K | -23.81K |
Depreciation & Amortization | - | - | - | - |
Stock-Based Compensation | - | - | - | - |
Other Working Capital | 517.35K | 31.15K | 2.85K | - |
Other Non-Cash Items | -2.78M | - | - | - |
Deferred Income Tax | - | - | - | - |
Change in Working Capital | 1.55M | 31.15K | 2.85K | - |
Operating Cash Flow | -818.77K | -4.24K | -461 | -23.81K |
Capital Expenditures | -4 | - | - | - |
Acquisitions | - | - | - | - |
Purchase of Investments | - | - | - | - |
Sales Maturities Of Investments | - | - | - | - |
Other Investing Acitivies | -33.83M | - | - | - |
Investing Cash Flow | -33.83M | - | - | - |
Debt Repayment | -1.20M | 800.00K | 100.00K | - |
Common Stock Repurchased | -36.00M | - | - | - |
Dividend Paid | - | - | - | - |
Other Financial Acitivies | 7.77M | -676.02K | 10.00K | 86.47K |
Financial Cash Flow | 34.54M | 123.98K | -57.44K | 86.47K |
Net Cash Flow | -109.08K | 119.74K | -57.90K | 62.65K |
Free Cash Flow | -818.77K | -4.24K | -461 | -23.81K |